Amylyx Pharmaceuticals (AMLX) shares were up 5.6% in recent Wednesday trading after Leerink upgraded the stock to outperform from market perform and adjusted its price target to $10 from $4.
Trading volume stood at over 1.6 million shares compared with a daily average of about 797,000.
Price: 4.91, Change: +0.26, Percent Change: +5.59